These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31138895)

  • 1. Effect of ovariectomy on the progression of chronic kidney disease-mineral bone disorder (CKD-MBD) in female Cy/+ rats.
    Vorland CJ; Lachcik PJ; Swallow EA; Metzger CE; Allen MR; Chen NX; Moe SM; Hill Gallant KM
    Sci Rep; 2019 May; 9(1):7936. PubMed ID: 31138895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
    Meng Y; Zhang H; Li Y; Li Q; Zuo L
    Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-acetylcysteine (NAC), an anti-oxidant, does not improve bone mechanical properties in a rat model of progressive chronic kidney disease-mineral bone disorder.
    Allen MR; Wallace J; McNerney E; Nyman J; Avin K; Chen N; Moe S
    PLoS One; 2020; 15(3):e0230379. PubMed ID: 32203558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidney Disease Progression Does Not Decrease Intestinal Phosphorus Absorption in a Rat Model of Chronic Kidney Disease-Mineral Bone Disorder.
    Vorland CJ; Biruete A; Lachcik PJ; Srinivasan S; Chen NX; Moe SM; Hill Gallant KM
    J Bone Miner Res; 2020 Feb; 35(2):333-342. PubMed ID: 31618470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Advanced Glycation End-Products (AGE) Lowering Drug ALT-711 on Biochemical, Vascular, and Bone Parameters in a Rat Model of CKD-MBD.
    Chen NX; Srinivasan S; O'Neill K; Nickolas TL; Wallace JM; Allen MR; Metzger CE; Creecy A; Avin KG; Moe SM
    J Bone Miner Res; 2020 Mar; 35(3):608-617. PubMed ID: 31743501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of triangle grass decoction on bone metabolism in rats with chronic kidney disease complicated with mineral and bone abnormalities.
    Liu L; Wang L; Li L; Wang H; Yuan L; Kang L; Jiang Q; Chen G; Lv N; Cui X; Huang L; Wu H; Xu J; Li Y
    J Ethnopharmacol; 2021 Jul; 275():114126. PubMed ID: 33872749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. R-568 reduces ectopic calcification in a rat model of chronic kidney disease-mineral bone disorder (CKD-MBD).
    Moe SM; Seifert MF; Chen NX; Sinders RM; Chen X; Duan D; Henley C; Martin D; Gattone VH
    Nephrol Dial Transplant; 2009 Aug; 24(8):2371-7. PubMed ID: 19258382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inositol 1,4,5-trisphosphate receptor type 2 is associated with the bone-vessel axis in chronic kidney disease-mineral bone disorder.
    Xiao Q; Tang Y; Luo H; Chen S; Tang Q; Chen R; Xiong L; Xiao J; Hong D; Wang L; Li G; Li Y
    Ren Fail; 2023 Dec; 45(1):2162419. PubMed ID: 36645057
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of ferric citrate and intravenous iron sucrose on markers of mineral, bone, and iron homeostasis in a rat model of CKD-MBD.
    Biruete A; Metzger CE; Chen NX; Swallow EA; Vrabec C; Clinkenbeard EL; Stacy AJ; Srinivasan S; O'Neill K; Avin KG; Allen MR; Moe SM
    Nephrol Dial Transplant; 2022 Sep; 37(10):1857-1867. PubMed ID: 35482713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathophysiology of early-stage chronic kidney disease-mineral bone disorder (CKD-MBD) and response to phosphate binders in the rat.
    Moe SM; Radcliffe JS; White KE; Gattone VH; Seifert MF; Chen X; Aldridge B; Chen NX
    J Bone Miner Res; 2011 Nov; 26(11):2672-81. PubMed ID: 21826734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid suppression therapy normalizes chronic kidney disease-induced elevations in cortical bone vascular perfusion: a pilot study.
    Aref MW; Swallow EA; Metzger CE; Chen N; Moe SM; Allen MR
    Osteoporos Int; 2019 Aug; 30(8):1693-1698. PubMed ID: 31069439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse Effects of Autoclaved Diets on the Progression of Chronic Kidney Disease and Chronic Kidney Disease-Mineral Bone Disorder in Rats.
    Biruete A; Srinivasan S; O'Neill KD; Vorland CJ; Hill Gallant KM; Cai W; Uribarri J; Johnston N; Allen MR; Chen NX; Moe SM
    Am J Nephrol; 2020; 51(5):381-389. PubMed ID: 32146472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rat model of chronic kidney disease-mineral bone disorder.
    Moe SM; Chen NX; Seifert MF; Sinders RM; Duan D; Chen X; Liang Y; Radcliff JS; White KE; Gattone VH
    Kidney Int; 2009 Jan; 75(2):176-84. PubMed ID: 18800026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intervention effect of zuogui pill on chronic kidney disease-mineral and bone disorder regulatory factor.
    Ma X; He L
    Biomed Pharmacother; 2018 Oct; 106():54-60. PubMed ID: 29957466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meta-analysis of randomized controlled trials of tonifying kidney and strengthen bone therapy on nondialysis patients with chronic kidney disease-mineral and bone disorder.
    Wu G; Li L; Wu Z
    Medicine (Baltimore); 2023 Jun; 102(25):e34044. PubMed ID: 37352066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality.
    Shalhoub V; Shatzen EM; Ward SC; Davis J; Stevens J; Bi V; Renshaw L; Hawkins N; Wang W; Chen C; Tsai MM; Cattley RC; Wronski TJ; Xia X; Li X; Henley C; Eschenberg M; Richards WG
    J Clin Invest; 2012 Jul; 122(7):2543-53. PubMed ID: 22728934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophy.
    Sabbagh Y; Graciolli FG; O'Brien S; Tang W; dos Reis LM; Ryan S; Phillips L; Boulanger J; Song W; Bracken C; Liu S; Ledbetter S; Dechow P; Canziani ME; Carvalho AB; Jorgetti V; Moyses RM; Schiavi SC
    J Bone Miner Res; 2012 Aug; 27(8):1757-72. PubMed ID: 22492547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Dietary Fiber Inulin Slows Progression of Chronic Kidney Disease-Mineral Bone Disorder (CKD-MBD) in a Rat Model of CKD.
    Biruete A; Chen NX; Metzger CE; Srinivasan S; O'Neill K; Fallen PB; Fonseca A; Wilson HE; de Loor H; Evenepoel P; Swanson KS; Allen MR; Moe SM
    JBMR Plus; 2023 Dec; 7(12):e10837. PubMed ID: 38130753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical porosity development and progression is mitigated after etelcalcetide treatment in an animal model of chronic kidney disease.
    Swallow EA; Metzger CE; Newman CL; Chen NX; Moe SM; Allen MR
    Bone; 2022 Apr; 157():116340. PubMed ID: 35085840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voluntary Wheel Running Has Beneficial Effects in a Rat Model of CKD-Mineral Bone Disorder (CKD-MBD).
    Avin KG; Allen MR; Chen NX; Srinivasan S; O'Neill KD; Troutman AD; Mast G; Swallow EA; Brown MB; Wallace JM; Zimmers TA; Warden SJ; Moe SM
    J Am Soc Nephrol; 2019 Oct; 30(10):1898-1909. PubMed ID: 31501355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.